Type 2 Diabetes (T2D) Clinical Trials

Find Type 2 Diabetes (T2D) Clinical Trials Near You

Prediction of Heart Failure and Cognitive Decline in Type 2 Diabetes : Longitudinal Cohort Study of Immuno-inflammation, Cardiac Energetics and Cognition.PreciDIAB-HEART&BRAIN

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Type 2 diabetes is a risk factor of heart failure and cognitive decline. Heart failure at its early stage is often silent. At present, primary prevention for heart failure is not available. Our aim is to identify diabetic patients at risk of heart failure in order to develop personalized preventive strategies. Type 2 diabetes is vascular and metabolic risk factor for cognitive decline though a direct lesional effect but also through an interaction with underlying neurodegenerative lesions. Our aim is to identify diabetic patients at risk of cognitive decline in order to develop personalized preventive strategies

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Adults

• Persons able to understand and object to the information provided.

• Type 2 diabetic patient free of heart failure ≥stade B

• Patient affiliated with a social security scheme.

• Patient agreeing to sign the informed consent form

Locations
Other Locations
France
Hopital Roger Salengro, CHU Lille
RECRUITING
Lille
Contact Information
Primary
Charlotte Cordonnier, MD,PhD
precidiab_heart_brain@chru-lille.fr
0320445962
Time Frame
Start Date: 2021-06-22
Estimated Completion Date: 2026-06
Participants
Target number of participants: 600
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Lille

This content was sourced from clinicaltrials.gov